- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (66)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (28)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (228)
- Breast Cancer (710)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (154)
- Colon Cancer (164)
- Colorectal Cancer (110)
- Endocrine Tumor (4)
- Esophageal Cancer (42)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (6)
- Kidney Cancer (124)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (288)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (98)
- Ovarian Cancer (172)
- Pancreatic Cancer (166)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (234)
- Skin Cancer (294)
- Skull Base Tumors (56)
- Spinal Tumor (12)
- Stomach Cancer (60)
- Testicular Cancer (28)
- Throat Cancer (90)
- Thymoma (6)
- Thyroid Cancer (98)
- Tonsil Cancer (30)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (620)
- Complementary Integrative Medicine (22)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (224)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (122)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (116)
- Molecular Diagnostics (8)
- Pain Management (64)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (880)
- Research (384)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (598)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (404)
- Survivorship (324)
- Symptoms (182)
- Treatment (1764)
Ewing’s sarcoma doesn’t keep teen from walking life’s road
3 minute read | Published June 30, 2016
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on June 30, 2016
In many ways, Jacob Ballard is a typical teenager. He likes soccer, is fascinated by robots and enjoys spending time with his friends.
But in some ways, the 17-year-old cancer survivor is completely different.
Since he was diagnosed with Ewing’s sarcoma in November 2014, Jacob has spent more than 120 days in the hospital and received more than 160 doses of chemotherapy. In March 2015, he also had an internal type I/II hemipelvectomy. The procedure removed a tumor — along with the entire left side of his pelvic bone.
A tough decision
“It was a hard, hard decision to make,” says his mother, Letha Ballard, of the surgery. “I cried and cried for weeks. In a way, you’re knowingly disabling your child. But Ewing’s sarcoma is an extremely aggressive form of cancer, so you have to assume it has micro-metastasized. Before, doctors would amputate limbs, and the Ewing’s sarcoma would still come back. So intense chemotherapy and surgery to remove the tumor are considered absolutely essential.”
The Ballard family made that tough decision with the help of Valerae Lewis, M.D., whom Letha calls “a miracle worker.”
“We had a surgery consultation at a different hospital before coming to MD Anderson for a second opinion,” Letha explains. “At one point, we had eight doctors in a room saying, ‘Don’t do this surgery. He will never walk again. His quality of life will suffer.’”
But Dr. Lewis, who started MD Anderson's Multidisciplinary Pelvic Sarcoma Program, showed the Ballards a video of her previous patients walking and told Jacob, “You will walk again. You will have a full, happy life.”
“That gave us confidence,” Letha says. “I wish everyone could come to Dr. Lewis.”
Beginning again after Ewing’s sarcoma
Jacob has since re-learned to walk and ride a bicycle, despite having no real hip joint on the left side of his body. (Instead, his femur is cradled by scar tissue and muscle.) He even completed a hard 15-mile hike over rough terrain just one year post-surgery.
“Yes, it was uncomfortable,” Jacob says. “But I was doing it with a bunch of friends, so I knew it would be fun. And I’m always in some degree of pain. I just ignore it.”
“Walking is tiring for him, and it does get painful after a while,” Letha adds. “But this is something our church does every four years, and it was important to Jacob. It’s a re-enactment of the pioneers moving west, and he followed a training plan developed by his physical therapist six days a week for five weeks leading up to it. It was a pretty remarkable thing for him to do, a real confidence-booster. A few adults were not able to finish, so it was a real inspiration, too.”
Moving forward after Ewing’s sarcoma
Today, Jacob continues to come in for regular follow-up scans and weekly physical therapy sessions. His goal is to build his stamina with an eye toward the future. And he has a very good reason for it.
“I have a Make-a-Wish trip coming up later this year,” Jacob says. “It’s to Disneyworld, and there’s going to be a lot of walking involved. Other patients who have done it told me they just used a wheelchair. But I said, ‘Nope. I don’t want to be riding in a wheelchair.’ I can’t run and jump anymore. But being able to walk is better than nothing. Now I’m trying to keep improving, so I can do all the walking I need to.”

Now I'm trying to keep improving, so I can do all the walking I need to.
Jacob Ballard
Survivor